Here are three things to know.
- The drug is approved to treat adults with complicated urinary tract infections, including a type of kidney infection called pyelonephritis.
- Vabomere is an intravenous combination drug made up of meropenem — an antibiotic — and vaborbactam, which inhibits certain resistance mechanisms used by bacteria.
- Rempex Pharmaceuticals’ expects Vabomere to hit the market in the fourth quarter of this year.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Samsung widens stake in prescription drug market through partnership with Japanese pharmaceutical company
Patients brace for price of ‘breakthrough’ leukemia drug CTL019
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
